Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen/Ionis’ Spinraza Data Shows Opportunity For Broad SMA Label

Nov 07 2016

• By Jessica Merrill

LabmicroscopeDNAgel_1200x675

Related Content

Keeping Track: Submissions For Dupilumab, Nusinersen; AbbVie Finds Breakthrough Space In Hep C

Oct 01 2016

Filings Soon As Biogen Snaps Up Ionis' Antisense Treatment

Aug 02 2016

Ionis Sells Kynamro To Kastle After Regaining Rights From Genzyme

May 03 2016

Related Companies

Biogen, Inc.

Ionis Pharmaceuticals, Inc.

Sanofi

Additional Topics

Commercial Rare Diseases Clinical Trials BioPharmaceutical Neurology

More from Neurological

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window